Search

everythinglearnresearchcommunity

for

Search:↓

Clinical exams are good for diagnosing some women's hair loss, but lab tests aren't always needed.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Testosterone improves mood and thinking skills; finasteride has no effect.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Moderately high prolactin levels do not cause hair loss in women.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Testosterone is crucial for development, growth, and various body functions in mammals.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Chromosomal differences affect how muscle cells respond to testosterone.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Herbal treatments can help manage PCOS symptoms.

Most women with PCOS have insulin resistance, especially those with phenotype B.

The document explains how male reproductive hormones work and affect the body.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Hyperthyroidism can hide signs of high androgen levels in females.

Young women with PCOS and no other heart risk factors have normal heart function.